Search Results
Nov 24, 2025, 10:27 ET Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
(BPDCN), an aggressive hematologic cancer, in the United States, Europe, and other global regions. In addition, Stemline commercializes selinexor, an XPO1 inhibitor for multiple myeloma, in Europe. The company is also conducting multiple label-expansion studies with elacestrant and tagraxofusp in breast
More news about: Menarini Industrie Farmaceutiche Riunite
Nov 24, 2025, 10:20 ET Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
(BPDCN), an aggressive hematologic cancer, in the United States, Europe, and other global regions. In addition, Stemline commercializes selinexor, an XPO1 inhibitor for multiple myeloma, in Europe. The company is also conducting multiple label-expansion studies with elacestrant and tagraxofusp in breast
More news about: Menarini Industrie Farmaceutiche Riunite
Nov 06, 2025, 17:31 ET Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immunotherapies | DelveInsight
(selinexor) is a first-in-class, oral Selective Inhibitor of Nuclear Export (SINE) compound. It binds to and inhibits the nuclear export protein XPO1, resulting in the retention and accumulation of tumor suppressor proteins within the nucleus. This restores and enhances their tumor-suppressing activity,
More news about: DelveInsight Business Research, LLP
Nov 03, 2025, 16:05 ET Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
compounds that address nuclear export dysregulation, a fundamental mechanism of oncogenesis. Karyopharm's lead compound and first-in-class, oral exportin 1 (XPO1) inhibitor, XPOVIO® (selinexor), is approved in the U.S. and marketed by the Company in three oncology indications. It has also received
More news about: Karyopharm Therapeutics Inc.
Nov 03, 2025, 07:00 ET Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress
XPOVIO is a first-in-class, oral exportin 1 (XPO1) inhibitor and the first of Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds for the treatment of cancer. XPOVIO functions by selectively binding to and inhibiting the nuclear export protein XPO1. XPOVIO is approved in the U.S. and marketed
More news about: Karyopharm Therapeutics Inc.
Oct 29, 2025, 06:00 ET Women In Trucking Association Names 2025 Top Companies for Women to Work in Transportation
Solutions, Peterbilt Motors Company, Quality Carriers, Inc., Roehl Transport, Inc., RXO, Ryder System, Inc., Schneider, Suburban Propane, L.P., UPS, WM and XPO, Inc. Companies named to the overall 2025 Top Companies for Women to Work in Transportation list are 4Refuel, Aim Transportation
More news about: Women In Trucking Association, Inc.
Oct 27, 2025, 07:00 ET Karyopharm to Report Third Quarter 2025 Financial Results on November 3, 2025
compounds that address nuclear export dysregulation, a fundamental mechanism of oncogenesis. Karyopharm's lead compound and first-in-class, oral exportin 1 (XPO1) inhibitor, XPOVIO® (selinexor), is approved in the U.S. and marketed by the Company in three oncology indications. It has also received
More news about: Karyopharm Therapeutics Inc.
Oct 20, 2025, 09:00 ET RedHill's Talicia® Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal
[email protected] Category: Corporate 1 IQVIA XPO Data on file 2 Chey W, Howden C, Moss S, et al. ACG Clinical Guideline: Treatment
More news about: RedHill Biopharma Ltd.
Oct 17, 2025, 15:30 ET Foxit to Attend Gartner® IT Symposium/Xpo™ 2025
greater agility within their digital infrastructure. About Gartner IT Symposium/Xpo 2025The Gartner IT Symposium/Xpo is the world's most important gathering for CIOs and IT executives. IT leaders attend to explore the latest innovations and insights
More news about: Foxit
Oct 14, 2025, 09:05 ET Verato to Host Expert Panel on Master Data Management and AI-Ready Transformation at Gartner® IT Symposium/Xpo™ 2025
Verato will be at Booth No. 119 at the Symposium. About the Gartner IT Symposium/Xpo 2025Gartner IT Symposium/Xpo is the world's most important gathering for CIOs and other IT executives. IT executives rely on these conferences to learn how to
More news about: Verato
Oct 13, 2025, 08:00 ET ConstructConnect Announces Gaurav Singal As Chief Technology Officer
the organization through a successful digital transformation. His previous experience includes serving as the Chief Product Officer for Last Mile at XPO Logistics; and Vice President of Technology at Goldman Sachs, where he drove electronic trading innovation and AI-powered compliance analytics.
More news about: ConstructConnect
Oct 09, 2025, 06:59 ET FMCG Logistics Market to Reach $1.7 Trillion, Globally, by 2033 at 3.9% CAGR: Allied Market Research
Worldwide Inc. Kuehne+Nagel DSV Db Schenker XPO Logistics, Inc. Geodis United Parcel Service Inc. A.P. Moller – Maersk
More news about: Allied Market Research
Oct 08, 2025, 07:00 ET Karyopharm Announces Strategic Financing Transactions to Support Growth; Extends Cash Runway Into Second Quarter of 2026, Beyond Expected Top-Line Readout of Phase 3 SENTRY Trial in Myelofibrosis
compounds that address nuclear export dysregulation, a fundamental mechanism of oncogenesis. Karyopharm's lead compound and first-in-class, oral exportin 1 (XPO1) inhibitor, XPOVIO® (selinexor), is approved in the U.S. and marketed by the Company in three oncology indications. It has also received regulatory
More news about: Karyopharm Therapeutics Inc.
Oct 07, 2025, 04:00 ET Flowable präsentiert Agentic AI und Intelligent Orchestration auf dem Gartner® IT Symposium/Xpo™ 2025 in Barcelona
Dies ist nach dem bevorstehenden Debüt auf dem IT Symposium/Xpo in Orlando bereits der zweite Auftritt von Flowable auf einem Gartner IT Symposium/Xpo im Jahr 2025. Flowable wird demonstrieren, wie seine Plattform Unternehmen dabei unterstützt, Arbeitsabläufe
More news about: Flowable AG
Oct 07, 2025, 04:00 ET Flowable présente son IA agentique et son orchestration intelligente au Gartner® IT Symposium/Xpo™ 2025 à Barcelone
service et IT Symposium/Xpo est une marque commerciale de Gartner, Inc. et/ou de ses sociétés affiliées aux États-Unis et à l'international et sont utilisées ici avec autorisation. Tous droits réservés. À propos du Gartner IT Symposium/Xpo 2025
More news about: Flowable AG
Oct 06, 2025, 08:00 ET RedHill Biopharma Signs New $1.8 Million Plus Sales Royalties Middle East Deal For Talicia®
[email protected] Category: Commercial 1 IQVIA XPO Data on file 2 Chey W, Howden C, Moss S, et al. ACG Clinical Guideline: Treatment of Helicobacter
More news about: RedHill Biopharma Ltd.
Oct 06, 2025, 06:52 ET Flowable presenta IA de agentes y orquestación inteligente en el Gartner® IT Symposium/Xpo™ 2025 en Barcelona
marca de servicio. IT Symposium/Xpo es una marca comercial de Gartner, Inc. y/o sus filiales en EE.UU. e internacionalmente, y se utilizan aquí con su autorización. Todos los derechos reservados. Acerca de Gartner IT Symposium/Xpo 2025
More news about: Flowable AG
Oct 06, 2025, 05:00 ET Flowable Brings Agentic AI and Intelligent Orchestration to the Gartner® IT Symposium/Xpo™ 2025 in Barcelona
This will mark Flowable's second appearance at a Gartner IT Symposium/Xpo in 2025, following the upcoming debut at the IT Symposium/Xpo, Orlando. Flowable will showcase how its platform helps enterprises unify workflows, orchestrate AI agents, and meet the
More news about: Flowable AG
Oct 06, 2025, 05:00 ET Flowable Brings Agentic AI and Intelligent Orchestration to the Gartner® IT Symposium/Xpo™ 2025 in Barcelona
(CCIB), Booth 301. This will mark Flowable's second appearance at a Gartner IT Symposium/Xpo in 2025, following the upcoming debut at the IT Symposium/Xpo, Orlando. Flowable will showcase how its platform helps enterprises unify workflows, orchestrate AI agents, and meet the
More news about: Flowable AG
Oct 02, 2025, 13:30 ET PECO Pallet Appoints Eric Sobanski as Chief Operating Officer
Prior to joining PECO in 2018, Dr. Sobanski was vice president of operational excellence at the Brink's Co. He also held leadership roles at XPO Logistics and Menlo Worldwide Logistics. He holds a bachelor's degree in industrial engineering from Kettering University, and
More news about: PECO Pallet, Inc.
Oct 02, 2025, 09:00 ET Flowable to Showcase Agentic AI and Intelligent Orchestration at Gartner® IT Symposium/Xpo™ 2025
meeting at Gartner IT Symposium/Xpo ™ 2025, please visit www.flowable.com. About the Gartner IT Symposium/Xpo 2025 Gartner
More news about: Flowable AG
Oct 01, 2025, 16:05 ET Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
compounds that address nuclear export dysregulation, a fundamental mechanism of oncogenesis. Karyopharm's lead compound and first-in-class, oral exportin 1 (XPO1) inhibitor, XPOVIO® (selinexor), is approved in the U.S. and marketed by the Company in three oncology indications. It has also received
More news about: Karyopharm Therapeutics Inc.
Oct 01, 2025, 10:24 ET CREATEA Mighty Mango Concept Beverage Will Be Unveiled at SupplySide Global 2025
non-sugar sweetener and flavor components responding to leading lifestyle trends in the beverage market. This new concept product expands on the successful XPO NRG concept beverage showcased at SupplySide 2024 (see video on the project here:
More news about: PricePlow
Sep 22, 2025, 11:31 ET Last Mile in E-commerce Delivery Market Surges to USD 201.54 Billion by 2033, Propelled by 7.84% CAGR - Verified Market Reports®
KEY COMPANIES PROFILED XPO, Fidelitone Last Mile Inc, SEKO Logistics, Gebrüder Weiss, United Parcel Service, Werner Enterprise, Ryder, JD.com, Inc, J.B. Hunt Transport, DHL, FedEx,
More news about: Verified Market Reports
Sep 18, 2025, 09:00 ET Automation Anywhere Accelerates Momentum through Strategic Customer Wins, "7 Wonders of AI" Recognition, and Breakthrough Product Innovations
recognition, and expanded AI innovation. The company will continue to showcase its leadership at upcoming events including AWS re:Invent and Gartner IT Symposium/Xpo. About Automation Anywhere Automation Anywhere is the leader in Agentic Process Automation (APA) and guided by its vision to
More news about: Automation Anywhere, Inc.